These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 7791208)
1. Back mutations to the TEM-1 beta-lactamase from TRC-1 lead to restored sensitivity to clavulanic acid. Thomson CJ; Amyes SG J Med Microbiol; 1995 Jun; 42(6):429-32. PubMed ID: 7791208 [TBL] [Abstract][Full Text] [Related]
2. Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors. Thomson CJ; Amyes SG J Antimicrob Chemother; 1993 May; 31(5):655-64. PubMed ID: 8392995 [TBL] [Abstract][Full Text] [Related]
3. TRC-1: emergence of a clavulanic acid-resistant TEM beta-lactamase in a clinical strain. Thomson CJ; Amyes SG FEMS Microbiol Lett; 1992 Mar; 70(2):113-7. PubMed ID: 1316862 [TBL] [Abstract][Full Text] [Related]
4. Molecular epidemiology of the plasmid-encoded TEM-1 beta-lactamase in Scotland. Thomson CJ; Amyes SG Epidemiol Infect; 1993 Feb; 110(1):117-25. PubMed ID: 8432315 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of mecillinam and amoxicillin/clavulanic acid against strains of Escherichia coli producing TEM-1, Oxa-1 and chromosomal beta-lactamases. Marre R; Schulz E Arzneimittelforschung; 1988 Jul; 38(7):863-5. PubMed ID: 3061383 [TBL] [Abstract][Full Text] [Related]
6. [Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolated in 1992 at the Cochin Hospital]. Bémer-Melchior P; Gilly L; Jugroot-Klotz K; Brun T; Névot P; Paul G Pathol Biol (Paris); 1995 Nov; 43(9):760-5. PubMed ID: 8746097 [TBL] [Abstract][Full Text] [Related]
7. Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to beta-lactamase inhibitors. Sirot D; Chanal C; Henquell C; Labia R; Sirot J; Cluzel R J Antimicrob Chemother; 1994 Jun; 33(6):1117-26. PubMed ID: 7928805 [TBL] [Abstract][Full Text] [Related]
8. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2. Payne DJ; Marriott MS; Amyes SG J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063 [TBL] [Abstract][Full Text] [Related]
9. A piperacillin-tazobactam resistant Escherichia coli strain isolated from a faecal sample of a healthy volunteer. London N; Thomson CJ; Amyes SG; Stobberingh E FEMS Immunol Med Microbiol; 1995 Apr; 11(2):107-11. PubMed ID: 7640670 [TBL] [Abstract][Full Text] [Related]
10. TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli. Paul GC; Gerbaud G; Bure A; Philippon AM; Pangon B; Courvalin P Antimicrob Agents Chemother; 1989 Nov; 33(11):1958-63. PubMed ID: 2692515 [TBL] [Abstract][Full Text] [Related]
11. Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics. Wu PJ; Shannon K; Phillips I Antimicrob Agents Chemother; 1994 Mar; 38(3):494-8. PubMed ID: 8203843 [TBL] [Abstract][Full Text] [Related]
12. Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid. Steingrube VA; Wallace RJ; Brown BA; Pang Y; Zeluff B; Steele LC; Zhang Y Antimicrob Agents Chemother; 1991 Mar; 35(3):524-8. PubMed ID: 2039203 [TBL] [Abstract][Full Text] [Related]
13. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production. Hsu LY; Chang SC; Luh KT; Hsieh WC Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798 [TBL] [Abstract][Full Text] [Related]
14. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Stapleton P; Wu PJ; King A; Shannon K; French G; Phillips I Antimicrob Agents Chemother; 1995 Nov; 39(11):2478-83. PubMed ID: 8585729 [TBL] [Abstract][Full Text] [Related]
15. Plasmid encoded beta-lactamases resistant to inhibition by clavulanic acid produced by calf faecal coliforms. Hunter JE; Corkill JE; McLennan AG; Fletcher JN; Hart CA Res Vet Sci; 1993 Nov; 55(3):367-70. PubMed ID: 8284502 [TBL] [Abstract][Full Text] [Related]
16. Substitution of Met-69 by Ala or Gly in TEM-1 beta-lactamase confer an increased susceptibility to clavulanic acid and other inhibitors. Madec S; Blin C; Krishnamoorthy R; Picard B; Chaibi el B; Fouchereau-Péron M; Labia R FEMS Microbiol Lett; 2002 May; 211(1):13-6. PubMed ID: 12052544 [TBL] [Abstract][Full Text] [Related]
17. Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. Blazquez J; Baquero MR; Canton R; Alos I; Baquero F Antimicrob Agents Chemother; 1993 Oct; 37(10):2059-63. PubMed ID: 8257123 [TBL] [Abstract][Full Text] [Related]
18. Reversal of clavulanate resistance conferred by a Ser-244 mutant of TEM-1 beta-lactamase as a result of a second mutation (Arg to Ser at position 164) that enhances activity against ceftazidime. Imtiaz U; Manavathu EK; Mobashery S; Lerner SA Antimicrob Agents Chemother; 1994 May; 38(5):1134-9. PubMed ID: 8067751 [TBL] [Abstract][Full Text] [Related]